In vitro activities of five new quinolones against 88 strains of Haemophilus influenzae and H. parainfluenzae isolated from genitourinary or neonatal infections were studied. All strains were susceptible, and MICs were similar to those for respiratory tract isolates. However, H. influenzae biotype IV appeared to be more susceptible to norfloxacin, enoxacin, and ciprofloxacin than the other biotypes were.
Haemophilus influenzae and H. parainfluenzae are common commensals of the oropharynx (1, 7, 13) . H. influenzae is frequently isolated from cases of infection or superinfection of the respiratory tract; capsulated strains cause meningitis and sepsis. Susceptibility of these strains to antibiotics is regularly checked. H. influenzae and H. parainfluenzae are also responsible for genital infections and neonatal sepsis. Both bacteria have been isolated from the vaginas of 0.2 to 2% of asymptomatic women (14) . Recently, a specific tropism of some strains for the genital tract (3, 14) ; these differences are discussed elsewhere (9) .
Biotypes were studied with the API 20E biochemical test (API System, Montalieu Vercieu, France) by the method of Holmes et al. (5) and were controlled with a specific Haemophilus identification system (HNID panel; American MicroScan, Campbell, Calif.). Capsular serotypes were determined upon isolation by slide agglutination with specific antisera (Difco Laboratories, Detroit, Mich.) and coagglu- H. influenzae biotype III (13) H. influenzae biotype IV (7) H. influenzae biotype V (4) H. influenzae biotype VI (4) H. influenzae biotype VII (1) H. parainfluenzae (14) (12) . Titered antibiotics were suspended according to the recommendations of the manufacturers. Constant volumes of increasing concentrations, from 0.008 to 8 mg/liter, were incorporated in MuellerHinton agar to which 5% Fildes enrichment medium (Difco Laboratories) was added. Approximately 104 bacteria were applied to the agar surface of the plates with an inoculumreplicating apparatus like that described by Steers. The last concentration inhibiting the culture was determined after a 48-h incubation at 37°C in conventional atmosphere. Staphylococcus aureus NCTC 6571 was used as a technical control.
Characterization of H. influenzae isolates showed that 11 were biotype I, 34 were biotype II, 13 were biotype III, 7 were biotype IV, 4 were biotype V, 4 were biotype VI, and 1 was biotype VII. Only four isolates were capsulated (three were serotype b and one was serotype a). Seven strains showed ,B-lactamase activity (one was biotype I, five were biotype II, and one was biotype IV). There were 3 biotype I and 11 biotype II isolates of H. parainfluenzae.
All 88 isolates of H. influenzae and H. parainfluenzae were susceptible to the five quinolones tested (Fig. 1 (Table 1) . Geometric mean MICs for the four prevalent biotypes (I, II, III, and IV) were compared using the Student t test. Biotypes I, II, and III showed no difference except for a greater susceptibility to pefloxacin for biotype III as compared with biotype II. Biotype IV appeared more susceptible to norfloxacin, enoxacin, and ciprofloxacin than biotypes I, II, and III and appeared more susceptible to pefloxacin than biotype II. Although differences were statistically significant, the small number of isolates belonging to biotype IV raises the question of how much these differences may be generalized. If valid, the differences indicate that strains of biotype IV are unique in H. influenzae. Only ofloxacin had an equal activity against H. influenzae biotypes I, II, III, and IV. A better knowledge of the mechanism of action of the quinolones could eventually shed light on this problem. Some data suggest that ofloxacin, aside from its action on bacterial DNA gyrase, might have another antibacterial action not inhibited by rifampin (11; J. T. Smith and N. T. Ratcliff, Abstr. 4th Mediterranean Congr. Chemother., abstr. no. 732, 1984) . However, a similar observation was made for ciprofloxacin and is not supported by our MIC results.
The seven f-lactamase-producing H. influenzae isolates were not more resistant to quinolones than were penicillinsusceptible isolates. New quinolones, because of their activity on 3-lactamase-producing gram-negative bacteria, might represent an alternative to broad-spectrum cephalosporin therapy for treatment of severe Haemophilus genital infections.
